Se H. Ahn
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2026
Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy.
Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy.
Journal: Journal of medicinal chemistry
Published: January 23, 2026
Design, Synthesis and Biological Evaluation of Pyrazolopyrimidine Derivatives as Aryl Hydrocarbon Receptor Antagonists for Colorectal Cancer Immunotherapy.
Journal: Pharmaceutics
Published: September 10, 2025
Neurochemical Effects of 4-(2Chloro-4-Fluorobenzyl)-3-(2-Thienyl)-1,2,4-Oxadiazol-5(4H)-One in the Pentylenetetrazole (PTZ)-Induced Epileptic Seizure Zebrafish Model.
Journal: International journal of molecular sciences
Published: December 21, 2020
Efficacy and pharmacokinetics evaluation of 4-(2-chloro-4-fluorobenzyl)-3-(2-thienyl)-1,2,4-oxadiazol-5(4H)-one (GM-90432) as an anti-seizure agent.
Journal: Neurochemistry international
Published: June 15, 2020
Identification of new arylsulfide derivatives as anti-melanogenic agents in a zebrafish model.
Journal: Bioorganic & medicinal chemistry letters
Published: February 06, 2020
Anti-inflammatory effect of a novel synthetic compound 1-((4-fluorophenyl)thio)isoquinoline in RAW264.7 macrophages and a zebrafish model.
Journal: Fish & shellfish immunology
Published: August 14, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026